Ardelyx (ARDX) Cash & Equivalents Growth (5y) (2018 - 2026)
Ardelyx (ARDX) Cash & Equivalents Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.98% |
| Dec 31, 2025 | -5.67% |
| Sep 30, 2025 | -14.04% |
| Jun 30, 2025 | -2.17% |
| Mar 31, 2025 | -21.88% |
| Dec 31, 2024 | -18.55% |
| Sep 30, 2024 | -12.54% |
| Jun 30, 2024 | -14.11% |
| Mar 31, 2024 | -17.05% |
| Dec 31, 2023 | -22.89% |
| Sep 30, 2023 | -14.76% |
| Jun 30, 2023 | -20.00% |
| Mar 31, 2023 | 6.42% |
| Dec 31, 2022 | 4.98% |
| Sep 30, 2022 | 0.72% |
| Jun 30, 2022 | -3.44% |
| Mar 31, 2022 | -7.94% |
| Dec 31, 2021 | -0.59% |
| Sep 30, 2021 | -14.03% |
| Jun 30, 2021 | -9.97% |